Juno Shares Surge as Company Enters Pact With Celgene, Will Get $1 Billion Payment
June 29 2015 - 4:51PM
Dow Jones News
By Josh Beckerman
Celgene Corp. will make an initial payment of about $1 billion,
including a stock purchase, as part of a ten-year collaboration
with Juno Therapeutics Inc. on cancer and autoimmune disease
treatments.
In after-hours trading, Juno shares were up more than 50% to
$69.35.
Write to Josh Beckerman at josh.beckerman@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024
